JORGE E CORTES to Drugs, Investigational
This is a "connection" page, showing publications JORGE E CORTES has written about Drugs, Investigational.
Connection Strength
0.069
-
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia. Blood. 2004 Apr 15; 103(8):2873-8.
Score: 0.052
-
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemia. Curr Hematol Malig Rep. 2007 May; 2(2):83-8.
Score: 0.017